ZA201804098B - Treatment of hand eczema - Google Patents

Treatment of hand eczema

Info

Publication number
ZA201804098B
ZA201804098B ZA2018/04098A ZA201804098A ZA201804098B ZA 201804098 B ZA201804098 B ZA 201804098B ZA 2018/04098 A ZA2018/04098 A ZA 2018/04098A ZA 201804098 A ZA201804098 A ZA 201804098A ZA 201804098 B ZA201804098 B ZA 201804098B
Authority
ZA
South Africa
Prior art keywords
treatment
hand eczema
oxopropanenitrile
diazaspiro
octan
Prior art date
Application number
ZA2018/04098A
Other languages
English (en)
Inventor
Wennberg Tero
Per Sørensen Anders
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55236207&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201804098(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of ZA201804098B publication Critical patent/ZA201804098B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
ZA2018/04098A 2016-01-21 2018-06-19 Treatment of hand eczema ZA201804098B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16152215 2016-01-21
PCT/EP2017/051133 WO2017125523A1 (en) 2016-01-21 2017-01-20 Treatment of hand eczema

Publications (1)

Publication Number Publication Date
ZA201804098B true ZA201804098B (en) 2024-10-30

Family

ID=55236207

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/04098A ZA201804098B (en) 2016-01-21 2018-06-19 Treatment of hand eczema

Country Status (31)

Country Link
US (3) US20200397787A1 (cg-RX-API-DMAC10.html)
EP (2) EP4257205A3 (cg-RX-API-DMAC10.html)
JP (1) JP6929860B2 (cg-RX-API-DMAC10.html)
KR (2) KR20180102662A (cg-RX-API-DMAC10.html)
CN (3) CN117159553A (cg-RX-API-DMAC10.html)
AU (3) AU2017209932A1 (cg-RX-API-DMAC10.html)
BR (1) BR112018014769A2 (cg-RX-API-DMAC10.html)
CA (1) CA3010547A1 (cg-RX-API-DMAC10.html)
CY (2) CY1126388T1 (cg-RX-API-DMAC10.html)
DK (1) DK3405197T3 (cg-RX-API-DMAC10.html)
ES (1) ES2963784T3 (cg-RX-API-DMAC10.html)
FI (2) FI3405197T3 (cg-RX-API-DMAC10.html)
FR (1) FR24C1053I2 (cg-RX-API-DMAC10.html)
HR (1) HRP20231448T1 (cg-RX-API-DMAC10.html)
HU (2) HUE064192T2 (cg-RX-API-DMAC10.html)
IL (4) IL320757A (cg-RX-API-DMAC10.html)
LT (2) LT3405197T (cg-RX-API-DMAC10.html)
MX (2) MX394358B (cg-RX-API-DMAC10.html)
NL (1) NL301306I2 (cg-RX-API-DMAC10.html)
NO (1) NO2024058I1 (cg-RX-API-DMAC10.html)
PL (1) PL3405197T3 (cg-RX-API-DMAC10.html)
PT (1) PT3405197T (cg-RX-API-DMAC10.html)
RS (1) RS64798B1 (cg-RX-API-DMAC10.html)
RU (1) RU2018130097A (cg-RX-API-DMAC10.html)
SG (2) SG10202006830WA (cg-RX-API-DMAC10.html)
SI (1) SI3405197T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202300415T1 (cg-RX-API-DMAC10.html)
TW (2) TWI783921B (cg-RX-API-DMAC10.html)
UA (1) UA123780C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017125523A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201804098B (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3968997T3 (fi) * 2019-05-15 2026-06-09 Leo Pharma As Delgositinibin formulaatio voiteen muodossa
CA3210150A1 (en) * 2021-02-02 2022-08-11 Pfizer Inc. Dosing regime for treatment of chronic hand eczema
KR20240027044A (ko) * 2021-07-30 2024-02-29 일라이 릴리 앤드 캄파니 바리시티닙을 사용한 손 습진의 치료
JP2026509302A (ja) 2023-03-17 2026-03-17 レオ ファーマ アクティーゼルスカブ 中等症ないし重症の慢性手湿疹を有する患者における慢性手湿疹を処置する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI466885B (zh) 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
US20130302298A1 (en) * 2010-11-30 2013-11-14 Bio-K Plus International Inc. Treatment and prevention of eczema
US20140343034A1 (en) * 2013-04-25 2014-11-20 Japan Tobacco Inc. Skin barrier function improving agent

Also Published As

Publication number Publication date
FR24C1053I1 (fr) 2025-02-21
WO2017125523A1 (en) 2017-07-27
SG11201805394QA (en) 2018-08-30
TW201736382A (zh) 2017-10-16
RU2018130097A (ru) 2020-02-21
CN117159554A (zh) 2023-12-05
JP2019502734A (ja) 2019-01-31
MX2018008449A (es) 2018-08-09
TWI841027B (zh) 2024-05-01
US20200397787A1 (en) 2020-12-24
HUS2400045I1 (hu) 2025-01-28
US20230138114A1 (en) 2023-05-04
SG10202006830WA (en) 2020-08-28
AU2022252766B2 (en) 2024-08-29
CY2024037I1 (el) 2026-02-25
JP6929860B2 (ja) 2021-09-01
EP3405197A1 (en) 2018-11-28
CN117159553A (zh) 2023-12-05
FIC20240048I1 (fi) 2024-12-19
AU2024266962A1 (en) 2024-12-19
KR20180102662A (ko) 2018-09-17
AU2017209932A1 (en) 2018-07-05
NO2024058I1 (no) 2024-12-13
UA123780C2 (uk) 2021-06-02
HUE064192T2 (hu) 2024-02-28
EP4257205A2 (en) 2023-10-11
NL301306I2 (nl) 2024-12-30
IL260094A (en) 2018-07-31
US20260216193A1 (en) 2026-07-30
LTPA2024538I1 (cg-RX-API-DMAC10.html) 2025-01-10
HRP20231448T1 (hr) 2024-03-01
CN108472297A (zh) 2018-08-31
RU2018130097A3 (cg-RX-API-DMAC10.html) 2020-05-25
TW202332451A (zh) 2023-08-16
EP4257205A3 (en) 2023-12-20
CY1126388T1 (el) 2026-02-25
IL297379A (en) 2022-12-01
NZ743582A (en) 2024-12-20
IL313543A (en) 2024-08-01
LT3405197T (lt) 2023-11-27
CY2024037I2 (el) 2026-02-25
PL3405197T3 (pl) 2024-02-12
EP3405197B1 (en) 2023-09-06
FR24C1053I2 (fr) 2025-12-05
AU2022252766A1 (en) 2022-11-03
IL320757A (en) 2025-07-01
SI3405197T1 (sl) 2024-03-29
CA3010547A1 (en) 2017-07-27
RS64798B1 (sr) 2023-11-30
FI3405197T3 (fi) 2023-11-23
KR20250088666A (ko) 2025-06-17
ES2963784T3 (es) 2024-04-02
BR112018014769A2 (pt) 2018-12-11
TWI783921B (zh) 2022-11-21
PT3405197T (pt) 2023-12-06
SMT202300415T1 (it) 2024-01-10
MX2022005915A (es) 2022-06-27
MX394358B (es) 2025-03-24
DK3405197T3 (da) 2023-11-27

Similar Documents

Publication Publication Date Title
ZA202500997B (en) Benzoxazepin oxazolidinone compounds and methods of use
PH12016501570A1 (en) Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists
TN2018000043A1 (en) Novel 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitors
CY1126388T1 (el) Χρηση delgocitinib για την θεραπεια χρονιουεκζεματος χεριων
CA2883210C (en) Bicyclic aza compounds as muscarinic m1 receptor agonists
PH12016501963B1 (en) Macrocyclic pyrimidine derivatives
MX2021001096A (es) 7-bencil-4-(2-metilbencilo)-2,4,6,7,8,9-hexahidroimidazo [1,2-a]pirido[3,4-e]pirimidin-5(1h)-ona, analogos y sales del mismo y su uso en terapia.
MX2016009403A (es) Compuestos heterociclicos.
GB201205669D0 (en) Bicyclic heterocyclic derivatives as mnk2 and mnk2 modulators and uses thereof
PH12019502365A1 (en) New bicyclic pyrazole derivatives
MX367913B (es) Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirimidina y 2,3-dihidro-1h-imidazo[1,2-b]pirazol sustituidos como inhibidores de ros1.
MX340574B (es) Imidazo pirazinas.
MX367914B (es) Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirazina sustituidos y derivados de 5,6,7,8-tetrahidro-4h-pirazolo[1,5-a][1 ,4]diazepina como inhibidores de ros1.
ZA202107300B (en) Treatment of cutaneous lupus erythematosus
ZA201801722B (en) Treatment of alopecia areata
PH12019500808A1 (en) Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof
GB2519470A (en) Bicyclic aza compounds as muscarinic M1 receptor agonists
NZ740690B2 (en) Treatment of alopecia areata